(90 days)
The MICROFIX QUICKANCHOR Plus is intended for fixation of soft tissue to bone, using suture, for the indications listed below: Hand: Repair/reconstruction of collateral ligaments, flexor and extensor tendon at the PIP (proximal interphalangeal), DIP (distal interphalangeal) and MCP (metacarpal interphalangeal) joints for all digits. Skull: Soft tissue attachment to the parietal, temporal ridge, frontal, mandible, maxilla, zygoma, and periorbital bones of the skull.
The MICROFIX QUICKANCHOR Plus is a bioabsorbable polymer implant designed for reattachment of soft tissue to bone. Similar to the currently marketed MICRO Anchor, the implant is mounted on a disposable inserter assembly and placement of the implant is facilitated via use of a sterile, disposable drill bit. There have been no modifications to the drill bit for use with the MICROFIX QUICKANCHOR Plus device.
Here's the analysis of the provided text regarding the acceptance criteria and study for the MICROFIX QUICKANCHOR Plus device:
1. Table of Acceptance Criteria and Reported Device Performance:
The provided document (K024115) is a 510(k) summary for a medical device seeking substantial equivalence to predicate devices, not a study detailing specific acceptance criteria and performance against those criteria. In these types of submissions, the "acceptance criteria" are implied by demonstrating substantial equivalence to existing, legally marketed devices.
Therefore, the "acceptance criteria" is that the device must be shown to be substantially equivalent to the predicate devices in terms of technological characteristics, safety, and performance.
| Acceptance Criteria | Reported Device Performance |
|---|---|
| Substantial Equivalence to predicate devices (MICRO Anchor, ReSolve QuickAnchor, BIOFASTIN RC suture anchors) in: | The MICROFIX QUICKANCHOR Plus has similar technological characteristics, design, and configuration compared with the predicate devices. |
| - Technological Characteristics | - Testing demonstrated that it is substantially equivalent to the predicate devices. |
| - Design and Configuration | - Suitable for its intended use. |
| - Safety and Performance Data | - Similarities in design, operating principles, biocompatibility, and sterilization method. |
| - Operating Principles | |
| - Biocompatibility | |
| - Sterilization Method | |
| Suitability for Intended Use (fixation of soft tissue to bone for specified indications) | - Testing demonstrated that it is suitable for the intended use specified. |
2. Sample size used for the test set and the data provenance:
- Sample Size for Test Set: Not applicable. This submission does not describe a clinical study with a "test set" of patients in the typical sense. The evaluation was primarily non-clinical.
- Data Provenance: Not applicable. No clinical data was used or generated for this submission. The "testing" mentioned is non-clinical.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:
- Not applicable. As no clinical test set was used, no experts were needed to establish ground truth from patient data. The ground truth, in the context of a 510(k), is implicitly established by the predicate devices being legally marketed and deemed safe and effective.
4. Adjudication method for the test set:
- Not applicable. No clinical test set or human interpretation was involved that would require an adjudication method.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:
- Not applicable. This device is a bioabsorbable polymer implant (suture anchor), not an AI-based diagnostic tool. No MRMC study or AI component is mentioned.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:
- Not applicable. This device is a physical implant, not an algorithm.
7. The type of ground truth used:
- The "ground truth" for this 510(k) submission is the established safety and efficacy profile of the predicate devices (MICRO Anchor, ReSolve QuickAnchor, and BIOFASTIN RC suture anchors). The new device is evaluated against these predicates through non-clinical testing to demonstrate similar performance and characteristics.
8. The sample size for the training set:
- Not applicable. This submission does not involve machine learning or AI, and therefore no "training set" in that context. The "training" in the context of device development would refer to the iterative design and testing process, but not a dataset for an algorithm.
9. How the ground truth for the training set was established:
- Not applicable. As there is no training set mentioned in the context of AI/ML, there is no ground truth established for it. The comparison is based on the known properties and regulatory approval of the predicate devices.
{0}------------------------------------------------
MAR 1 3 2003
249 Vanderbilt Avenue Norwood, MA 02062 Registration #1221934 Ruth C. Forstadt Contact Person: Tel: (781) 251-3188 (781) 278-9578 Fax: E-mail:rforstad(@ethus.jnj.com December 2, 2002 Date Summary Prepared: MICROFIX QUICKANCHOR Plus Device Trade Name: Common name: Biodegradable Fixation Fastener Fastener, Fixation, Biodegradable Soft Tissue Classification Name: (Class II, 21 CFR 888.3030, Product code: 87 MAI) MICRO Anchor, ReSolve QuickAnchor and Predicate Device(s): BIOFASTIN RC suture anchors The MICROFIX QUICKANCHOR Plus is a Device Description: bioabsorbable polymer implant designed for reattachment of soft tissue to bone. Similar to the currently marketed MICRO Anchor, the implant is mounted on a disposable inserter assembly and placement of the implant is facilitated via use of a sterile, disposable drill bit. There have been no modifications to the drill bit for use with the MICROFIX QUICKANCHOR Plus device. Intended Use: The MICROFIX QUICKANCHOR Plus is intended for fixation of soft tissue to bone for the indications listed below: Hand: Repair/reconstruction of collateral ligaments, flexor and extensor tendon at the PIP (proximal interphalangeal), DIP (distal interphalangeal) and MCP (metacarpal interphalangeal) joints for all digits
Skull: Soft tissue attachment to the parietal, temporal ridge, frontal, mandible, maxilla, zygoma, and perioorbital bones of the skull.
{1}------------------------------------------------
Kod 4115
510(k) Summary (page 2 of 2)
| Technological Characteristics: | The proposed device has similar technological characteristics and is similar in design and configuration compared with the predicate devices. |
|---|---|
| Summary of Non-clinical Test: | Testing conducted to characterize performance of the MICROFIX QUICKANCHOR Plus has demonstrated that it is substantially equivalent to the predicate devices and is suitable for the intended use specified. |
| Clinical Data: | Not Applicable |
| Conclusion: | Based on 1) safety and performance data, and 2) similarities in design, operating principles, biocompatibility and sterilization method, the MICROFIX QUICKANCHOR Plus has been shown to be substantially equivalent to predicate devices under the Federal Food, Drug and Cosmetic Act. |
.
{2}------------------------------------------------
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" arranged around the perimeter. Inside the circle is a stylized image of an eagle with three lines representing its wings and body.
MAR 1 3 2003
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Ms. Ruth C. Forstadt Senior Regulatory Affairs Associate Mitek Worldwide 249 Vanderbilt Avenue Norwood, MA 02062
Re: K024115
Trade/Device Name: Mitek Microfix Quickanchor Plus Regulation Number: 21 CFR 888.3040 Regulation Name: Smooth or threaded metallic bone fixation fastener Regulatory Class: II Product Code: HWC Dated: December 12, 2002 Received: December 13, 2002
Dear Ms. Forstadt:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
{3}------------------------------------------------
Page 2 - Ms. Ruth C. Forstadt
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97) you may obtain. Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Mark N. Mulkerson
Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{4}------------------------------------------------
Page 1 of
510(k) Number (if known): K o 2 4/1
Device Name: MICROFIX QUICKANCHOR Plus
The MICROFIX QUICKANCHOR Plus is intended for fixation of soft tissue to bone, using suture, for the indications listed below:
Hand: Repair/reconstruction of collateral ligaments, flexor and extensor tendon at the PIP (proximal interphalangeal), DIP (distal interphalangeal) and MCP (metacarpal interphalangeal) joints for all digits.
Skull: Soft tissue attachment to the parietal, temporal ridge, frontal, mandible, maxilla, zygoma, and periorbital bones of the skull.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use (Per 21 CFR 801.109)
OR
Over-the -Counter Use No
Mark A. Milhursin
Division Sign Off
510(k) Number K024115
§ 888.3040 Smooth or threaded metallic bone fixation fastener.
(a)
Identification. A smooth or threaded metallic bone fixation fastener is a device intended to be implanted that consists of a stiff wire segment or rod made of alloys, such as cobalt-chromium-molybdenum and stainless steel, and that may be smooth on the outside, fully or partially threaded, straight or U-shaped; and may be either blunt pointed, sharp pointed, or have a formed, slotted head on the end. It may be used for fixation of bone fractures, for bone reconstructions, as a guide pin for insertion of other implants, or it may be implanted through the skin so that a pulling force (traction) may be applied to the skeletal system.(b)
Classification. Class II.